Equnies Patents

List of Patents

Patents granted

  1. A method for preparation of a diagnostic kit useful forecasting Equine Herpes virus-I disease (Patent has been notified on 25.10.2003 and classified as 55E4-1891278).
  1. A method for preparing complement fixation test based (Cofeb) kit for diagnosis of Babesiaequi infection of equines (Patent has been granted 31.07.2009 and Patent No.196690). Later on, patent was abandoned due to poor commercial viability in present context.
  2. A recombinant haemagglutinin domain-containing protein for the detection and diagnosis of glanders and method of preparation thereof. (Patent No.296824 dated 16.05.2018, Application No.1328/DEL/2010 dated 08.06.2010)
  1. Nano-drug delivery for quinapyramine sulphate (Patent No.310429 dated 29.03.2019, Application, No.2560/DEL/2011, dated 06.09.2011). Name of Inventors: AnjuManuja, NeerajDilbaghi, Sandeep Kumar, HarmanmeetKaur, GauravBhanjana, Rajender Kumar, Balvinder Kumar and S.C. Yadav.
  1. Recombinant TssA protein for detection of antibodies against Burkoholderia mallei and uses thereof (Patent No. 354870, dated 30.12.2020, Application No. 3610/DEL/2015, dated 04.11.2015). Name of inventors: Hari Shankar Singha, Praveen Malik, Sachin Kumar Goyal, S.K. Khurana and R.K. Singh.
  1. Polymeric metal nanocomposites andmethods of synthesis thereof(Patent No. 411620, dated 16.11.2022, Application No.201911009696, Dated 13.03.2019). Name of inventors: AnjuManuja, Balvinder Kumar, Riyesh T. and B. N. Tripathi
  1. Hydroxychloroquine/chloroquine zinc oxide nanoparticle formulation (Patent No. 542925, dated 25.06.2024, Application No.202111057698, dated 11.12.2021)Name of inventors:AnjuManuja, Balvinder Kumar, Rajender Kumar, Yash Pal andMinakshi P.

Patents filed

  1. A recombinant haemagglutinin domain-containing protein for the detection and diagnosis of glanders and method of preparation thereof.
  2. Polynucleotide sequence, processes, composition and methods thereof-
  3. Nano-drug delivery for quinapyramine sulphate
  4. A highly sensitive kit for detection of antibodies against Theileriaequi in serum of equids.
  5. Recombinant TssA protein for detection of antibodies against Burkoholderia mallei and uses thereof.
  6. Recombinant Hcp1 protein for detection of antibodies against Burkoholderia mallei in Equines
  7. Aervajavanica extract for the treatment of exuberant granulation tissue and tumors in horses.
  8. Polymeric metal nanocomposites and methods of synthesis thereof
  9. A modified vaccine construct for EHV1 and methods of preparing the same
  10. Monoclonal antibody based immunoasssay for detection of equine influenza (H3N8) antigen
  11. Mutated EHV-1(TOH Strain) genome based vaccine construct and method for preparation
  12. Recombinant nucleocapsid protein based indirect ELISA kit for detection of anti SARS-COV-2 antibodies in canines
  13. Hydroxychloroquine/chloroquine zinc oxide nanoparticle formulation.
  14. Recombinant antigens based indirect ELISA kit for detection of anti Trypanosoma evansi antibodies in animals.
  15. Development of a Novel Modified Attenuated Lumpy Skin Disease Virus (LSDV) For Use as Vaccine
  16. A novel vaccine formulation (Ancovax) to prevent SARS-CoV-2 infection in animals.
  17. A method for encapsulation of bacteriophage cocktail against Salmonella sp for oral delivery in poultry.
  18. Development of a Novel test to differentiate the vaccine and field strains of LSDV.
  19. miR-29a serves as a novel immunovirological marker to predict the functionality of immune response to Lumpy Skin Disease virus infection.
  20. Chitosan-Alginate-Zinc Artificial Skin Construct
  21. Phage endolysin encapsulated antimicrobial formulation to ameliorate biofilms